LAULETTA, GIANFRANCO
 Distribuzione geografica
Continente #
NA - Nord America 4.229
EU - Europa 1.098
AS - Asia 977
SA - Sud America 308
AF - Africa 13
OC - Oceania 2
Totale 6.627
Nazione #
US - Stati Uniti d'America 4.198
CN - Cina 373
SE - Svezia 301
BR - Brasile 285
SG - Singapore 284
HK - Hong Kong 206
RU - Federazione Russa 191
IT - Italia 138
DE - Germania 111
UA - Ucraina 108
FI - Finlandia 81
GB - Regno Unito 73
CA - Canada 21
BE - Belgio 20
VN - Vietnam 20
FR - Francia 19
IN - India 19
ID - Indonesia 17
IE - Irlanda 12
AR - Argentina 11
NL - Olanda 9
TR - Turchia 9
BD - Bangladesh 8
CZ - Repubblica Ceca 7
PK - Pakistan 7
AT - Austria 6
PL - Polonia 6
UZ - Uzbekistan 6
ES - Italia 5
MX - Messico 5
IQ - Iraq 4
MA - Marocco 4
VE - Venezuela 4
LT - Lituania 3
NP - Nepal 3
ZA - Sudafrica 3
AU - Australia 2
AZ - Azerbaigian 2
BG - Bulgaria 2
BO - Bolivia 2
EG - Egitto 2
HU - Ungheria 2
IR - Iran 2
JO - Giordania 2
JP - Giappone 2
KR - Corea 2
LB - Libano 2
NI - Nicaragua 2
PH - Filippine 2
PY - Paraguay 2
TN - Tunisia 2
AL - Albania 1
CO - Colombia 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EC - Ecuador 1
EE - Estonia 1
GE - Georgia 1
KE - Kenya 1
KG - Kirghizistan 1
KW - Kuwait 1
MK - Macedonia 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
UY - Uruguay 1
Totale 6.627
Città #
Fairfield 623
Chandler 414
Woodbridge 391
Ashburn 318
Seattle 254
Cambridge 252
Jacksonville 245
Nyköping 238
Houston 232
Hong Kong 205
Wilmington 188
Singapore 187
Ann Arbor 172
Beijing 95
Roxbury 76
Lawrence 73
Nanjing 70
New York 70
Des Moines 52
Bari 46
Princeton 46
Santa Clara 41
Boardman 39
Inglewood 37
Brooklyn 34
San Diego 27
Nanchang 24
Hebei 23
Brussels 20
Dong Ket 20
Shenyang 20
London 19
Los Angeles 19
Jakarta 17
Helsinki 16
Jiaxing 15
São Paulo 15
Tianjin 14
Pune 13
Belo Horizonte 12
Dublin 12
Moscow 12
Changsha 10
Guangzhou 10
Jinan 10
The Dalles 10
Grafing 9
Toronto 9
Munich 8
Ostuni 8
San Francisco 8
Nuremberg 7
Brno 6
Dearborn 6
Falls Church 6
Frankfurt am Main 6
Hounslow 6
Paris 6
Rome 6
Tashkent 6
Charlotte 5
Goiânia 5
Guarulhos 5
Manaus 5
Montreal 5
Shanghai 5
Tappahannock 5
Brasília 4
Brescia 4
Council Bluffs 4
Hangzhou 4
João Pessoa 4
Marseille 4
Milan 4
Napoli 4
Norwalk 4
Petrópolis 4
Porto Alegre 4
Secaucus 4
Vienna 4
Washington 4
Atlanta 3
Boston 3
Chicago 3
Curitiba 3
Falkenstein 3
Fortaleza 3
Hefei 3
Kilburn 3
Madrid 3
Modugno 3
Ningbo 3
Noci 3
Pescara 3
Phoenix 3
Rende 3
Rio de Janeiro 3
San Jose 3
San Mateo 3
São Gonçalo 3
Totale 4.981
Nome #
PDCD1 and IFNL4 genetic variants and risk of developing hepatitis C virus-related diseases 154
Hepatitis C virus clearance after direct-acting antivirals in cirrhotic patients by stages of liver impairment: the ITAL-C network study 148
Clinical Significance of Polymorphisms in Immune Response Genes in Hepatitis C-Related Hepatocellular Carcinoma 138
HCV clearance after direct-acting antivirals in patients with cirrhosis by stages of liver impairment: The ITAL-C network study 137
Clinical practice: hepatitis C virus infection, cryoglobulinemia and cryoglobulinemic vasculitis 136
A different perspective on sofosbuvir-ledipasvir treatment of patients with HCV genotype 1b cirrhosis: The ital-c network study 135
HCV-related liver and lymphoproliferative diseases: association with polymorphisms of IL28B and TLR2 133
SVR12 rates higher than 99% after sofosbuvir/velpatasvir combination in HCV infected patients with F0-F1 fibrosis stage: A real world experience 126
CD5/CD20 expression on circulating B cells in HCV-related chronic hepatitis and mixed cryoglobulinemia 126
null 122
The lymphoid system in hepatitis C virus infection: autoimmunity, mixed cryoglobulinemia, and overt B-cell malignancy 121
IN SITU SIMULTANEOUS DETECTION OF HEPATITIS C VIRUS RNA AND HEPATITIS C VIRUS-RELATED ANTIGENS IN HEPATOCELLULAR CARCINOMA 120
HCV RNA genomic sequences and HCV-E2 glycoprotein in sural nerve biopsies from hcv-infected patients with peripheral neuropathy 120
ANGPT2 and NOS3 polymorphisms and clinical outcome in advanced hepatocellular carcinoma patients receiving sorafenib 120
Hepatitis C virus infection and mixed cryoglobulinemia 115
B CELLS AND HCV: AN INFECTION MODEL OF AUTOIMMUNITY 115
Transarterial Chemoembolization Plus Sorafenib: A Sequential Therapeutic Scheme for HCV-Related Intermediate-Stage Hepatocellular Carcinoma: A Randomized Clinical Trial. 114
Role of the receptor for the globular domain of C1q protein in the pathogenesis of hepatitis C virus-related cryoglobulin vascular damage 111
B-cell depletion in the treatment of mixed cryoglobulinemia. 108
Combined Effects of 2 Interleukin 28B Polymorphisms on the Therapeutic Outcome of Hepatitis C Patients With Circulating Cryoglobulins 108
Detection and quantitation of HCV core protein in single hepatocytes by means of laser capture microdissection and enzyme-linked immunosorbent assay 106
Direct-acting antiviral agents in the therapy of hepatitis C virus-related mixed cryoglobulinaemia: a single-centre experience 105
INCREASED SERUM LEVELS OF THE CHEMOKINE CXCL13 AND UP-REGULATION OF ITS GENE EXPRESSION ARE DISTINCTIVE FEATURES OF HCV-RELATED CRYOGLOBULINEMIA AND CORRELATE WITH ACTIVE CUTANEOUS VASCULITIS 97
Barrett's esophagus and esophageal cancer: An overview. 97
HEPATITIS C VIRUS RNA AND CORE PROTEIN IN KIDNEY GLOMERULAR AND TUBULAR STRUCTURES ISOLATED WITH LASER CAPTURE MICRODISSECTION 97
Hepatitis C virus infection and mixed cryoglobulinemia: a striking association 97
null 96
Role of B-cell attracting chemokine-1 in HCV-related cryoglobulinemic vasculitis 95
eNOS polymorphisms and clinical outcome in advanced HCC patients receiving sorafenib: Final results of the ePHAS study 94
MONOCLONAL ANTIBODY TREATMENT OF MIXED CRYOGLOBULINEMIA RESISTANT TO INTERFERON ALPHA WITH AN ANTI-CD20 93
HCV-ASSOCIATED B CELL CLONALITIES IN THE LIVER DO NOT CARRY THE T(14; 18) CHROMOSOMAL TRANSLOCATION 90
Non-enveloped HCV core protein as constitutive antigen of cold-precipitable immune complexes in type II mixed cryoglobulinaemia 86
MIXED CRYOGLOBULINEMIA: A MODEL OF VIRUS-RELATED DISEASE IN INTERNAL MEDICINE 86
Intrahepatic B cell clonal expansions and extrahepatic manifestations of chronic HCV infection 86
Features of peripheral CD8+CD57+ lymphocytes in patients with autoimmune hemolytic anemia 85
Caratterizzazione di lesione metastatica da carcinoma della mammella con angioecografia. Caso clinico 84
C4d: a valuable marker of activation of the classical complement pathway in mixed cryoglobulinemia 84
H. pylori infection and gastric cancer: state of the art (review). 83
Short-Term Variations in Neutrophil-to-Lymphocyte and Urea-to-Creatinine Ratios Anticipate Intensive Care Unit Admission of COVID-19 Patients in the Emergency Department 81
IMMUNOCHEMICAL AND BIOMOLECULAR STUDIES OF CIRCULATING IMMUNE COMPLEXES ISOLATED FROM PATIENTS WITH ACUTE AND CHRONIC HEPATITIS C VIRUS INFECTION 80
Cryoglobulinemic Vasculitis 78
null 78
Antikörper gegen hepatitis-C-viren in humanen intravenösen immunoglobulinen. 72
HCV, Mixed Cryoglobulinemia and Malignant Lymphoproliferation 72
Impact of Cryoglobulinemic Syndrome on the Outcome of Chronic Hepatitis C Virus Infection: A 15-Year Prospective Study. 70
REPLY TO THE LETTER TO THE EDITOR "ANDROGEN DEPRIVATION THERAPY AND RISK OF RHEUMATOID ARTHRITIS IN PATIENTS WITH LOCALIZED PROSTATE CANCER" by YANG et al. 69
Espansione clonale dei linfociti B intraepatici ottenuti da portatori cronici del virus C dell'epatite (HCV) con e senza crioglobulinemia mista 67
Potential neutralizing properties of anti-E2 antibodies in HCV-infected patients with lymphoproliferative disorders. 66
PEGYLATED INTERFERON-A, RIBAVIRIN AND RITUXIMAB COMBINED THERAPY OF HEPATITIS C VIRUS-RELATED MIXED CRYOGLOBULINEMIA: A LONG-TERM STUDY 65
Bevacizumab Plus FOLFOX-4 Combined With Deep Electro-Hyperthermia as First-line Therapy in Metastatic Colon Cancer: A Pilot Study 65
VIROLOGICAL ANALYSIS AND PHENOTIPIC CHARACTERIZATION OF PERIPHERAL BLOOD LYMPHOCYTES OF HEPATITIS C VIRUS-INFECTED PATIENTS WITH AND WITHOUT MIXED CRYOGLOBULINEMIA 63
Imaging evaluation of pulmonary and non-ischaemic cardiovascular manifestations of covid-19 63
Crioglobulinemia mista e infezione da HCV 62
null 61
T cell receptor variable beta gene repertoire in liver and peripheral blood lymphocytes of chronically hepatitis C virus-infected patients with and without mixed cryoglobulinaemia 60
Double filtration plasmapheresis in the treatment of leg ulcers in the course of type IHCV-positive cryoglobulinemia 58
Basi molecolari dell’associazione tra virus epatite e carcinoma epatocellulare 58
Cellule ematopoietiche staminali CD34+ e infezione cronica da virus C dell'epatite 58
Assessment of total Hepatitis C virus (HCV) core protein in HCV-related mixed cryoglobulinemia. 58
In reply. Transarterial chemoembolization plus sorafenib... 56
Vasculiti primarie sistemiche 56
Alcolizzazione percutanea del piccolo HCC. Casistica personale 53
Association Between Mixed Cryoglobulinemia, Translocation (14;18), and Persistence of Occult HCV Lymphoid Infection After Treatment 53
Espansione clonale dei linfociti B intraepatici ottenuti da portatori cronici del virus C dell'epatite con e senza crioglobulinemia mista 52
Trattamento con interferone pegilato-α2b in monoterapia o in associazione con ribavirina e amantadina in pazienti affetti da epatite cronica attiva HCV-correlata non responsivi a interferone non-pegilato 51
Mieloma multiplo e gammapatie monoclonali: quadri clinici, acquisizioni eziopatogenetiche e progressi terapeutici 50
A Challenging Case of Visceral Leishmaniasis 49
Safety and effectiveness of biosimilar of Rituximab CT-P10 in the treatment of cryoglobulinemic vasculitis: the MARBLe study (Mixed cryoglobulinemiA Rituximab BiosimiLar) 48
null 47
La vasculite crioglobulinemica: aspetti clinico-patogenetici 46
Natural interferon-Α versus its combination with 6-methyl prednisolone in the therapy of type II mixed cryoglobulinemia: a long-term randomized, controlled study 46
Le tecniche di biologia molecolare nello studio dei tessuti fissati e paraffinati 44
ROLE OF THE RECEPTOR FOR THE GLOBULAR DOMAIN OF C1Q PROTEIN IN THE PATHOGENESIS OF CRYOGLOBULIN-RELATED VASCULAR DAMAGE 43
Trattamento antivirale in pazienti affetti da epatite cronica attiva HCV correlata e transaminasi normali 39
Immunodetection of hepatitis C virus (HCV)-related antigens in tissues: problems and perspectives 38
Pegylated interferon-alpha, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study 37
Lung Ultrasound Is Useful for Evaluating Lung Damage in COVID-19 Patients Treated with Bamlanivimab and Etesevimab: A Single-Center Pilot Study 36
Autoimmune Hepatitis: Factors Involved in Initiation and Methods of Diagnosis and Treatment 36
A Novel Automatic Algorithm to Support Lung Ultrasound Non-Expert Physicians in Interstitial Pneumonia Evaluation: A Single-Center Study 35
Serum IgM in type II mixed cryoglobulinemia recognize HCV E2 peptides 34
Termoablazione a radiofrequenza vs alcolizzazione percutanea nel trattamento del piccolo epatocarcinoma. Studio prospettico, randomizzato 29
Role of the receptor for the globular domain of C1q protein in the pathogenesis of HCV-related cryoglobulin vascular damage 28
Double-filtration plasmapheresis in the treatment of leg ulcers in cryoglobulinemia 26
COVID-19 vaccination rate and safety profile in a multicentre Italian population affected by mixed cryoglobulinaemic vasculitis 25
Hepatitis C virus productive infection in mononuclear cells from patients with cryoglobulinemia 25
Interleukin 28B gene polymorphisms in hepatitis C virus-related cryoglobulinemic vasculitis. 25
Immune disturbance leads to pulmonary embolism in COVID-19 more than classical risk factors: a clinical and histological study 24
The wide spectrum of cryoglobulinemic vasculitis and an overview of therapeutic advancements 23
Management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian Study Group of Cryoglobulinemia (GISC) 21
COVID-19 and Mixed Cryoglobulinemia Syndrome: Long-Term Survey Study on the Prevalence and Outcome, Vaccine Safety, and Immunogenicity 20
P87 MEDIASTINAL SYNDROME REVEALED HEART LOCALIZATION OF A PRIMARY MEDIASTINAL B-CELL LYMPHOMA 20
Terapia della sindrome crioglobulinemica 18
Hepatitis B virus-infection related cryoglobulinemic vasculitis. Clinical manifestations and the effect of antiviral therapy: A review of the literature 17
Cryoglobulinemia: the "cold" problem in cardiac surgery, a single-center experience and a literature review 16
Pulmonary Embolism in COVID-19 Patients Is Not Related to a Deterioration of Tissue Oxygenation 13
Hepatitis C virus-related autoimmunity before and after viral clearance: a single center, prospective, observational study 11
Totale 6.862
Categoria #
all - tutte 30.561
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.561


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202043 0 0 0 0 0 0 0 0 0 0 0 43
2020/2021965 67 116 63 75 111 54 75 66 85 129 68 56
2021/2022661 48 89 9 23 26 55 28 29 41 52 114 147
2022/20231.097 146 117 78 98 105 168 14 153 169 4 25 20
2023/2024380 33 77 16 25 34 93 20 19 4 8 4 47
2024/20251.504 35 25 131 44 31 147 200 140 58 79 235 379
Totale 6.862